dr. wierda on using cd19-targeted car t cells in cll
Published 4 years ago • 183 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:26
dr. wierda discusses use of car t cells in cll
-
1:26
dr. weirda discusses use of car t cells in cll
-
1:02
dr. wierda on immunotherapy agents for patients with cll
-
1:01
findings for cd19-targeted car t cells in combination with ibrutinib in cll
-
2:42
dr. wierda on targeted therapies for cll
-
1:57
dr. wierda on chemoimmunotherapy in cll
-
1:13
dr. wierda discusses the need for newer therapies in cll
-
1:10
dr. wierda on frontline management of patients with cll
-
1:24
dr. park on using cd19-targeted car t cells as treatment for all
-
1:25
dr. wierda discusses the role of ibrutinib in cll
-
1:23
dr. wierda on the ascend trial and btk inhibitor-based therapies in cll
-
9:33
long-term trial supports cd19-targeted car t cells for relapsed/refractory cll
-
1:03
dr. brentjens on cd19-targeted t cells in cll and all
-
2:07
dr. wierda on factors to consider in frontline management of cll
-
1:39
dr. wierda on role of rituximab biosimilar in evolving cll treatment paradigm
-
0:45
dr. wierda discusses watchful waiting in cll
-
2:11
dr. wierda on ibrutinib resistance in cll
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
2:13
dr. wierda on frontline therapy for older cll patients compared to younger